Citigroup Inc Edwards Lifesciences Corp Transaction History

Citigroup Inc

$163 Billion
Q4 2024

A detailed history of Citigroup Inc transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Citigroup Inc holds 841,191 shares of EW stock, worth $63.9 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares

841,191

Previous 995,880 15.53%

Holding current value

$63.9 Million

Previous $65.7 Million 5.24%

% of portfolio

0.04%

Previous 0.04%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 12, 2025	SELL	$64.54 - $75.92 $9.98 Million - $11.7 Million	-154,689 Reduced 15.53%	841,191 $62.3 Million
Q3 2024 Nov 12, 2024	BUY	$59.7 - $93.78 $30.5 Million - $48 Million	511,530 Added 105.61%	995,880 $65.7 Million
Q2 2024 Aug 12, 2024	BUY	$84.3 - $94.31 $11.3 Million - $12.6 Million	133,945 Added 38.23%	484,350 $44.7 Million
Q1 2024 May 10, 2024	SELL	$72.54 - $95.56 $1.73 Million - $2.28 Million	-23,853 Reduced 6.37%	350,405 $33.5 Million
Q4 2023 Feb 09, 2024	SELL	$61.71 - $77.76 $3.16 Million - $3.99 Million	-51,283 Reduced 12.05%	374,258 $28.5 Million
Q3 2023 Nov 09, 2023	SELL	$69.28 - $93.38 $4.87 Million - $6.56 Million	-70,288 Reduced 14.18%	425,541 $29.5 Million
Q2 2023 Aug 10, 2023	SELL	$81.41 - $94.33 $2.39 Million - $2.77 Million	-29,362 Reduced 5.59%	495,829 $46.8 Million
Q1 2023 May 11, 2023	BUY	$74.26 - $84.51 $6.89 Million - $7.84 Million	92,745 Added 21.45%	525,191 $43.4 Million
Q4 2022 Feb 09, 2023	SELL	$68.3 - $87.44 $1.27 Million - $1.62 Million	-18,566 Reduced 4.12%	432,446 $32.3 Million
Q3 2022 Nov 10, 2022	BUY	$82.37 - $107.29 $6.83 Million - $8.9 Million	82,945 Added 22.54%	451,012 $37.3 Million
Q2 2022 Aug 10, 2022	BUY	$86.5 - $128.27 $3.63 Million - $5.39 Million	41,990 Added 12.88%	368,067 $35 Million
Q1 2022 May 12, 2022	SELL	$101.96 - $128.34 $3.27 Million - $4.12 Million	-32,112 Reduced 8.97%	326,077 $38.4 Million
Q4 2021 Feb 10, 2022	SELL	$106.37 - $130.68 $1.45 Million - $1.79 Million	-13,677 Reduced 3.68%	358,189 $46.4 Million
Q3 2021 Nov 10, 2021	BUY	$102.91 - $122.75 $38.3 Million - $45.6 Million	371,866 New	371,866 $42.1 Million

Others Institutions Holding EW

# of Institutions

1,373

Shares Held

475M

Call Options Held

9.51M

Put Options Held

3.93M

View Full List

About Edwards Lifesciences Corp

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $47B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

More about EW

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Citigroup Inc, based on Form 13F filings with the SEC.

News

Stay updated on Citigroup Inc with notifications on news.

Account